TERRI TURNER: Open Payments
NPI 1972838183 · MOREHEAD CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 24 payments from 12 companies in 2025. Trend: 2023 $361 · 2024 $319 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| ABBVIE INC. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: CAPLYTA, FARXIGA, REXULTI, VRAYLAR, Veozah, TRINTELLIX, AIRSUPRA, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
